DoReMi Trial: Milrinone vs Dobutamine for Treatment of Cardiogenic Shock – REBEL EM

Medical CategoriesAbdominal and GastroinstestinalAllergy and ImmunologyCardiovascularDermatologyEMS and DisasterEndocrine, Metabolic, Fluid, and ElectrolytesEnvironmentalEthical and LegalHead, Eye, Ear, Nose, and ThroatHematology and OncologyInfectious DiseaseNeurologyObstetrics and GynecologyOrthopedicsPediatricsProcedures and SkillsPyschobehavioralRenal and GenitourinaryResuscitationThoracic and RespiratoryToxicologyTrauma